Gene expression predictors in breast cancer: Current status, limitations and perspectives

被引:34
作者
Desmedt, C. [3 ]
Ruiz-Garcia, E. [1 ,2 ]
Andre, F. [1 ,2 ]
机构
[1] Univ Paris 11, Inst Gustave Roussy, Translat Res Unit, UPRES EA 03535, F-94805 Villejuif, France
[2] Univ Paris 11, Inst Gustave Roussy, Dept Med Oncol Com 050, F-94805 Villejuif, France
[3] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
关键词
Breast cancer; Gene expression profiles; Prognosis; Prediction;
D O I
10.1016/j.ejca.2008.09.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast Cancer is characterised by a wide heterogeneity regarding outcome and drug sensitivity A better prediction of these two parameters at the individual level should improve patient management and therefore also improve both the quality of life and the overall survival of the patient. Several molecular predictors for prognosis (MammaPrint (R) or Oncotype DX) and drug prediction (DLD30, SET index) have been generated using DNA-based arrays or RT-PCR, some of these being tested in phase III trials. Although they exhibit good metric performance and should improve the quality of care in the next decade, these predictors are considered suboptimal regarding the potential of the technology. New study design and arrays should generate more powerful second generation gene signatures. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2714 / 2720
页数:7
相关论文
共 35 条
[1]   Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools [J].
Ach, Robert A. ;
Floore, Arno ;
Curry, Bo ;
Lazar, Vladimir ;
Glas, Annuska M. ;
Pover, Rob ;
Tsalenko, Anya ;
Ripoche, Hugues ;
Cardoso, Fatima ;
d'Assignies, Mahasti Saghatchian ;
Bruhn, Laurakay ;
Van't Veer, Laura J. .
BMC GENOMICS, 2007, 8 (1)
[2]  
Andre F, 2007, BREAST CANC RES TREA
[3]   Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer [J].
Andre, Fabrice ;
Hatzis, Christos ;
Anderson, Keith ;
Sotiriou, Christos ;
Mazouni, Chafika ;
Mejia, Jaime ;
Wang, Bailang ;
Hortobagyi, Gabriel N. ;
Symmans, W. Fraser ;
Pusztai, Lajos .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2061-2067
[4]   Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy [J].
Andre, Fabrice ;
Pusztai, Lajos .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (11) :621-632
[5]   Linking oncogenic pathways with therapeutic opportunities [J].
Bild, Andrea H. ;
Potti, Anil ;
Nevins, Joseph R. .
NATURE REVIEWS CANCER, 2006, 6 (09) :735-U13
[6]   Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].
Buyse, Marc ;
Loi, Sherene ;
van't Veer, Laura ;
Viale, Giuseppe ;
Delorenzi, Mauro ;
Glas, Annuska M. ;
d'Assignies, Mahasti Saghatchian ;
Bergh, Jonas ;
Lidereau, Rosette ;
Ellis, Paul ;
Harris, Adrian ;
Bogaerts, Jan ;
Therasse, Patrick ;
Floore, Arno ;
Amakrane, Mohamed ;
Piette, Fanny ;
Rutgers, Emiel ;
Sotiriou, Christos ;
Cardoso, Fatima ;
Piccart, Martine J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192
[7]   Clinical application of the 70-gene profile: The MINDACT trial [J].
Cardoso, Fatima ;
Van't Veer, Laura ;
Rutgers, Emiel ;
Loi, Sherene ;
Mook, Stella ;
Piccart-Gebhart, Martine J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :729-735
[8]   Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients [J].
de Azambuja, E. ;
Cardoso, F. ;
de Castro, G., Jr. ;
Colozza, M. ;
Mano, M. S. ;
Durbecq, V. ;
Sotiriou, C. ;
Larsimont, D. ;
Piccart-Gebhart, M. J. ;
Paesmans, M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (10) :1504-1513
[9]   Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes [J].
Desmedt, Christine ;
Haibe-Kains, Benjamin ;
Wirapati, Pratyaksha ;
Buyse, Marc ;
Larsimont, Denis ;
Bontempi, Gianluca ;
Delorenzi, Mauro ;
Piccart, Martine ;
Sotiriou, Christos .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5158-5165
[10]   Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series [J].
Desmedt, Christine ;
Piette, Fanny ;
Loi, Sherene ;
Wang, Yixin ;
d'assignies, Mahasti Saghatchian ;
Bergh, Jonas ;
Lidereau, Rosette ;
Ellis, Paul ;
Harris, Adrian L. ;
Klijn, Jan G. M. ;
Foekens, John A. ;
Cardoso, Fatima ;
Piccart, Martine J. ;
Buyse, Marc ;
Sotiriou, Christos .
CLINICAL CANCER RESEARCH, 2007, 13 (11) :3207-3214